Doxorubicin and trabectedin for recurrent leiomyosarcoma – A case report

Autor: Levin, Gabriel, Gilbert, Lucy, Leung, Shuk On Annie, Zeng, Xing, Mandilaras, Victoria, Bernard, Laurence

Publikováno v: In Gynecologic Oncology Reports October 2024 55

TP53 mutations in high grade serous ovarian cancer and impact on clinical outcomes: a comparison of next generation sequencing and bioinformatics analyses.

Autor: Mandilaras, Victoria, Garg, Swati, Cabanero, Michael, Tan, Qian, Pastrello, Chiara, Burnier, Julia, Karakasis, Katherine, Wang, Lisa, Neesha, C Dhani, Marcus, O Butler, Philippe, L Bedard, Lillian, L Siu, Clarke, Blaise, Patricia, Ann Shaw, Stockley, Tracy, Jurisica, Igor, Amit, M Oza, Lheureux, Stephanie

Publikováno v: International Journal of Gynecological Cancer; Feb2019, Vol. 29 Issue 2, p346-352, 7p

Updates and current challenges in microRNA research for personalized medicine in ovarian cancer

Autor: Mandilaras, Victoria, Vernon, Mégane, Meryet-Figuière, Matthieu, Karakasis, Katherine, Lambert, Bernard, Poulain, Laurent, Oza, Amit, Denoyelle, Christophe, Lheureux, Stephanie

Publikováno v: Expert Opinion on Biological Therapy; August 2017, Vol. 17 Issue: 8 p927-943, 17p

ASSESSING CARBOPLATIN A N D EVEROLIMUS.

Autor: Mandilaras, Victoria¹, Bouganim, Nathaniel¹, Asselah, Jamil¹

Publikováno v: Oncology Exchange. Feb2015, Vol. 14 Issue 1, p30-31. 2p.

Repurposing Itraconazole and Hydroxychloroquine to Target Lysosomal Homeostasis in Epithelial Ovarian Cancer.

Autor: Marastoni S; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Madariaga A; Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Autonomous University of Barcelona, Barcelona, Spain., Pesic A; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Nair SN; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Li ZJ; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Shalev Z; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Ketela T; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Colombo I; Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Mandilaras V; Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Cabanero M; Department of Pathology, Toronto General Hospital, Toronto, Ontario, Canada., Bruce JP; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Li X; Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Garg S; Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Wang L; Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Chen EX; Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Gill S; Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Dhani NC; Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Zhang W; Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Pintilie M; Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Bowering V; Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Koritzinsky M; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada., Rottapel R; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Wouters BG; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada., Oza AM; Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Joshua AM; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Kinghorn Cancer Centre, Department of Medical Oncology, St Vincents Hospital, Sydney, Australia.; Garvan Institute of Medical Research, Sydney, Australia., Lheureux S; Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.

Publikováno v: Cancer research communications [Cancer Res Commun] 2022 May 04; Vol. 2 (5), pp. 293-306. Date of Electronic Publication: 2022 May 04 (Print Publication: 2022).